Imatinib Activates Pathological Hypertrophy by Altering Myocyte Calcium Regulation

Abstract

These data show that imatinib can activate pathological hypertrophic signaling pathways by altering intracellular Ca(2+) dynamics. This is likely a contributing mechanism for the adverse cardiac effects of imatinib.